Pharmaceutical Process Development: Current Chemical and Engineering Challenges
Pharmaceutical process research and development is an exacting, multidisciplinary effort but a somewhat neglected discipline in the chemical curriculum. This book presents an overview of the many facets of process development and how recent advances in synthetic organic chemistry, process technology and chemical engineering have impacted on the manufacture of pharmaceuticals. In 15 concise chapters the book covers such diverse subjects as route selection and economics, the interface with medicinal chemistry, the impact of green chemistry, safety, the crucial role of physical organic measurements in gaining a deeper understanding of chemical behaviour, the role of the analyst, new tools and innovations in reactor design, purification and separation, solid state chemistry and its role in formulation. The book ends with an assessment of future trends and challenges. The book provides a valuable overview of: both early and late stage chemical development, how safe and scaleable synthetic routes are designed, selected and developed, the importance of the chemical engineering, analytical and manufacturing interfaces, the key enabling technologies, including catalysis and biocatalysis, the importance of the green chemical perspective and solid form issues. The book, written and edited by experts in the field, is a contemporary, holistic treatise, with a logical sequence for process development and mini-case histories within the chapters to bring alive different aspects of the process. It is completely pharmaceutical themed, encompassing all essential aspects, from route and reagent selection to manufacture of the active compound. The book is aimed at both graduates and postgraduates interested in a career in the pharmaceutical industry. It informs them about the breadth of the work carried out in chemical research and development departments, and gives them a feel for the challenges involved in the job. The book is also of value to academics who often understand the drug discovery arena, but have far less appreciation of the drug development area, and are thus unable to advise their students about the relative merits of careers in chemical development versus discovery.
Pharmaceutical Process Development: Current Chemical and Engineering Challenges, The Royal Society of Chemistry, 2011.
Download citation file:
Digital access
Print format
Table of contents
-
Introductionp1-14ByA. John Blacker;A. John BlackerUniversity of LeedsInstitute of Process Research and Development, Leeds, LS2 9JT, UKSearch for other works by this author on:Mike T. WilliamsMike T. Williams133 London Road, Deal, Kent, C14 9TYUKSearch for other works by this author on:
-
Chapter 2: Process Research and Development in the Pharmaceutical Industry: Origins, Evolution and Progressp15-38ByTrevor LairdTrevor LairdScientific Update LLPMaycroft Place, Mayfield, East Sussex, TN20 6EWUKSearch for other works by this author on:
-
Chapter 3: Active Pharmaceutical Ingredients: Structure and Impact on Synthesisp39-65ByJohn S. Carey;John S. CareyGlaxoSmithKline PharmaceuticalsOld Powder Mills, near Leigh, Tonbridge, TN11 9ANUKSearch for other works by this author on:Dave LaffanDave LaffanAstraZeneca PR&D, Silk Road Business ParkMacclesfield, SK10 2NAUKSearch for other works by this author on:
-
Chapter 4: Rapid Early Development of Potential Drug Candidatesp66-89ByNicholas M. Thomson;Nicholas M. ThomsonPfizer LtdResearch Active Pharmaceutical Ingredients, Ramsgate Road, Sandwich, Kent, CT13 9NJUKSearch for other works by this author on:Pieter D. de Koning;Pieter D. de KoningPfizer LtdResearch Active Pharmaceutical Ingredients, Ramsgate Road, Sandwich, Kent, CT13 9NJUKSearch for other works by this author on:Adam T. Gillmore;Adam T. GillmorePfizer LtdResearch Active Pharmaceutical Ingredients, Ramsgate Road, Sandwich, Kent, CT13 9NJUKSearch for other works by this author on:Yong TaoYong TaoPfizer IncResearch Active Pharmaceutical Ingredients, Eastern Point Road, Groton, CT 06340USASearch for other works by this author on:
-
Chapter 5: Route Design and Selectionp90-116ByMike ButtersMike ButtersPharmaceutical DevelopmentAstraZeneca, Avlon Works, Severn Road, Bristol, BS10 7ZEUKSearch for other works by this author on:
-
Chapter 6: The Importance of Green Chemistry in Process Research & Developmentp117-137ByPeter J. DunnPeter J. DunnPfizer Worldwide Research and DevelopmentSandwich Laboratories, Kent, CT13 9NJUKSearch for other works by this author on:
-
Chapter 7: Kinetic Approaches for Faster and Efficient Process Developmentp138-159BySuju P. MathewSuju P. MathewChemical Research and DevelopmentPfizer Global Research and Development, SandwichCT13 9NJUKSearch for other works by this author on:
-
Chapter 8: The Design of Safe Chemical Reactions: It's No Accidentp160-177ByDavid J. DaleDavid J. DaleThe BriarsClavertye, Elham, Kent, CT4 6YEUKSearch for other works by this author on:
-
Chapter 9: Physicochemical Data Requirements for the Design of Fine Chemical Processes: Acquisition and Applicationp178-208ByJohn H. AthertonJohn H. AthertonDepartment of Chemical and Biological SciencesUniversity of Huddersfield, Queensgate, Huddersfield, HD1 3DHUKSearch for other works by this author on:
-
Chapter 10: Liquid–Liquid Extraction for Process Development in the Pharmaceutical Industryp209-237ByIan F. McConvey;Ian F. McConveyAstraZenecaPharmaceutical Development, Charterway, Silk Road Business Park, Macclesfield, Cheshire, SK10 2NAUKSearch for other works by this author on:Paul NancarrowPaul NancarrowSchool of Chemistry and Chemical EngineeringQueen's University Belfast, Stranmillis Road, Belfast, BT9 5AG, Northern IrelandUKSearch for other works by this author on:
-
Chapter 11: Development Enabling Technologiesp238-259ByMike J. Monteith;Mike J. MonteithGlaxoSmithKlineFive Moore Drive, Research Triangle ParkNC 27709USASearch for other works by this author on:Mark B. MitchellMark B. MitchellGlaxoSmithKlineFive Moore Drive, Research Triangle ParkNC 27709USASearch for other works by this author on:
-
Chapter 12: The Analytical Interface and the Impact on Pharmaceutical Process Developmentp260-285BySimon Hamilton;Simon HamiltonMSD Ltd (a subsidiary of Merck & Co., Inc)Hertford Road, Hoddesdon, Hertfordshire, EN11 9BUUKSearch for other works by this author on:Alexia BertrandAlexia BertrandMSD Ltd (a subsidiary of Merck & Co., Inc)Hertford Road, Hoddesdon, Hertfordshire, EN11 9BUUKSearch for other works by this author on:
-
Chapter 13: Materials Science: Solid Form Design and Crystallisation Process Developmentp286-316ByKevin Roberts;Kevin RobertsInstitute of Particle Science and Engineering and Institute of Process Research and DevelopmentSchool of Process, Environmental and Materials Engineering, University of Leeds, LS2 9JTUKSearch for other works by this author on:Robert Docherty;Robert DochertyPharmaceutical SciencesPfizer Global R&D, Ramsgate Road, Sandwich, Kent, CT13 9NJUKSearch for other works by this author on:Stefan TaylorStefan TaylorPharmaceutical SciencesPfizer Global R&D, Ramsgate Road, Sandwich, Kent, CT13 9NJUKSearch for other works by this author on:
-
Chapter 14: Technology Transfer of an Active Pharmaceutical Ingredientp317-330ByStephen McGhie;Stephen McGhieTechnical Shared ServiceGlobal Manufacturing and Supply, GlaxoSmithKline, Shewalton Road, Irvine, KA11 5APUKSearch for other works by this author on:Stuart YoungStuart YoungNew Product Introduction Centre of ExcellenceGlobal Manufacturing and Supply, GlaxoSmithKline, Temple Hill, Dartford, DA1 5APUKSearch for other works by this author on:
-
Chapter 15: Future Trends and Challengesp331-341ByA. John Blacker;A. John BlackerUniversity of LeedsInstitute of Process R&D, Leeds, LS2 9JTUKSearch for other works by this author on:Mike T. WilliamsMike T. Williams133 London Road.Deal, Kent, C14 9TYUKSearch for other works by this author on:
Spotlight
Advertisement
Advertisement